View Older Stories View More Recent Stories
-
US Foods Announces Upsizing and Pricing of Secondary Public Offering of Common Stock
-
Willis Towers Watson Prices Offering of $650,000,000 of Senior Notes
-
Form 13F-NT BMO CAPITAL MARKETS CORP For: Mar 31
-
Whole Foods Market (WFM) PT Raised to $30 at BMO Capital Following 1Q Report; 'Raising EPS on Cost Savings & Buyback'
-
Pacific Ethanol to Participate in the 12th Annual BMO Capital Markets Farm to Market Conference
-
SunOpta Scheduled to Present at the BMO Capital Markets 12th Annual Farm to Market Conference on May 17, 2017
-
Merck (MRK) PT Raised to $74 at BMO Capital; Keytruda 1L-Lung Approval a 'Meaningful Positive'
-
Bunge Limited to Address BMO Capital Markets 12th Annual Farm to Market Conference
-
Methanex to Present at BMO Capital Markets 12th Annual Farm to Market Conference
-
US Foods Announces Launch of Secondary Public Offering of Common Stock
-
Snyder’s-Lance, Inc. to Present at the BMO Capital Markets 12th Annual Farm to Market Conference
-
CareTrust REIT, Inc. Prices $300.0 Million of Senior Notes due 2025
-
Primo Water to Present at Upcoming Investor Conferences
-
UPDATE: Ionis Pharma (IONS) Defended at BMO Capital - FDA Warning Letter Is Unwarranted
-
Anglo Pacific Group PLC: Result of AGM
-
AgroFresh Solutions to Present at the BMO Capital Markets 12th Annual Farm to Market Conference
-
MyoKardia (MYOK):
-
Anglo Pacific Group PLC Q1 2017 Trading Update
-
Omega Protein to Present at the 12th Annual BMO Farm to Market Conference
-
Renewable Energy Group to Present at Upcoming Investor Conferences
-
Media Advisory - BMO Financial Group to Announce its Second Quarter 2017 Results
-
Mallinckrodt plc (MNK) PT Lowered to $69 at BMO Capital Following 1Q In-Line EPS; 'Upside in Generics May Not be Sustainable
-
Levine Leichtman Capital Partners Sells Champion Manufacturing, Inc.
-
Horizon Pharma (HZNP) PT Lowered to $17 at BMO Capital; '1Q Primary Care Disappointment Overshadows Orphan Progress'
-
Newell Rubbermaid (NWL) PT Raised to $51 at BMO Capital on 1Q EPS Beat; 'Growth was Broad-Based'
-
First Data Corporation (FDC) PT Raised to $19 at BMO Capital on In-Line EPS; 'North America Acquiring Growth, Improving but Gradually'
-
Pandora (P) PT Lowered to $12 at BMO Capital
-
BMO Capital Downgrades Cisco (CSCO) to Market Perform
-
Darling Ingredients to Participate in May Investor Conferences in New York
-
CareTrust REIT, Inc. Announces Launch of Offering of $300.0 Million of Senior Notes due 2025
-
BMO Capital Starts Warrior Met Coal LLC. (HCC) at Outperform
-
Dollar slips after weaker-than-expected U.S. inflation, sales data
-
CF Industries Holdings, Inc. to Participate in Upcoming Investor Conferences
-
Real Matters Inc. Files Final Prospectus and Announces Pricing of Initial Public Offering of Common Shares
-
Viacom (VIAB) PT Lowered to $42 at BMO Capital; Reiterates Market Perform
-
Dunkin' Brands (DNKN) PT Raised to $52 at BMO Capital
-
Regeneron Pharma (REGN) PT Raised to $421 at BMO Capital; 'Too Early to Make a Call on Dupixent Launch'
-
Global Payments (GPN) PT Raised to $93 at BMO Capital; 'Beat on Fundamentals'
-
The Andersons, Inc. (ANDE) PT Lowered to $39 at BMO Capital
-
Incyte (INCY) PT Raised to $146 at BMO Capital
-
EnergySolutions (ES) PT Raised to $61 at BMO Capital; 'Awaiting Key NPT Decisions'
-
Black Hills Corp (BKH) PT Raised to $74 at BMO Capital
-
CF Industries (CF) PT Lowered to $35 at BMO Capital; 'Summer Pain Could Give Way to Better Days'
-
Delphi Automotive PLC (DLPH) PT Raised to $104 at BMO Capital; 'Value Unlocked With Strategic Seperation'
-
Oil States International (OIS) PT Lowered to $33 at BMO Capital; 'Lowering Estimates Due to Slower Completions Segment Growth'
-
UPDATE: DeVry (DV) PT Raised to $40 at BMO Capital; 'Mixed Results' (CORRECTION)
-
2U, Inc. (TWOU) PT Raised to $50 at BMO Capital; 'Solid Execution; Guidance Raised; More on GetSmarter Deal'
-
Houghton Mifflin (HMHC) PT Raised to $13 at BMO Capital; 'Seasonally Light but Good Quarter, Expect More at Investor Day'
-
Cross Country Healthcare (CCRN) PT Lowered to $15 at BMO Capital; 'Speed Bump, Not Cliff Diving'
-
Intercept Pharmaceuticals (ICPT) PT Raised to $223 at BMO Capital; 'Ocaliva Off to a Strong Start'

